Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Price

Showing results (451-460 of 500) with videos related to

Pageof 50
Sort By:
Nature Immunology|April 30, 2025
Identification of soluble biomarkers that associate with distinct manifestations of long COVIDYu Gao, Curtis Cai, Sarah Adamo, et al.
Plos One|November 15, 2007
CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variationJohn T Loffredo, Thomas C Friedrich, Enrique J León, et al.
Plos One|September 3, 2011
GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivoLara Vojnov, Mauricio A Martins, Jorge R Almeida, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Machine Learning Analysis of Post-Acute COVID Symptoms Identifies Distinct Clusters, Severity Groups, and TrajectoriesBeverly Peng, Thomas Dalhuisen, Aidan Rogers, et al.
Gastroenterology|February 16, 2019
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8<sup>+</sup> T Cells and Evolve at the Population LevelHadi Karimzadeh, Muthamia M Kiraithe, Valerie Oberhardt, et al.
BMJ Open|November 22, 2011
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsAngela M Minassian, Rosalind Rowland, Natalie E R Beveridge, et al.
The Journal of Experimental Medicine|October 8, 2008
Macaques vaccinated with live-attenuated SIV control replication of heterologous virusMatthew R Reynolds, Andrea M Weiler, Kim L Weisgrau, et al.
Nature Methods|August 15, 2022
VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2Mikhail Goncharov, Dmitry Bagaev, Dmitrii Shcherbinin, et al.
ACS Medicinal Chemistry Letters|December 1, 2015
Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic TreatmentMark Ammirati, Scott W Bagley, Samit K Bhattacharya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaquesAnna Hryniewicz, David A Price, Marcin Moniuszko, et al.
Pageof 50

Showing results (451-460 of 500) with videos related to

Sort By:
Pageof 50
Nature Immunology|April 30, 2025
Identification of soluble biomarkers that associate with distinct manifestations of long COVIDYu Gao, Curtis Cai, Sarah Adamo, et al.
Plos One|November 15, 2007
CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variationJohn T Loffredo, Thomas C Friedrich, Enrique J León, et al.
Plos One|September 3, 2011
GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivoLara Vojnov, Mauricio A Martins, Jorge R Almeida, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Machine Learning Analysis of Post-Acute COVID Symptoms Identifies Distinct Clusters, Severity Groups, and TrajectoriesBeverly Peng, Thomas Dalhuisen, Aidan Rogers, et al.
Gastroenterology|February 16, 2019
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8<sup>+</sup> T Cells and Evolve at the Population LevelHadi Karimzadeh, Muthamia M Kiraithe, Valerie Oberhardt, et al.
BMJ Open|November 22, 2011
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsAngela M Minassian, Rosalind Rowland, Natalie E R Beveridge, et al.
The Journal of Experimental Medicine|October 8, 2008
Macaques vaccinated with live-attenuated SIV control replication of heterologous virusMatthew R Reynolds, Andrea M Weiler, Kim L Weisgrau, et al.
Nature Methods|August 15, 2022
VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2Mikhail Goncharov, Dmitry Bagaev, Dmitrii Shcherbinin, et al.
ACS Medicinal Chemistry Letters|December 1, 2015
Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic TreatmentMark Ammirati, Scott W Bagley, Samit K Bhattacharya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaquesAnna Hryniewicz, David A Price, Marcin Moniuszko, et al.
Pageof 50